$YBCN
Yong Bai Chao New Retail Corp

2022 Q1 Form 10-Q Financial Statement

#000147793222003757 Filed on May 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $20.21K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.21K $6.000K
YoY Change 236.75%
Operating Profit -$20.21K -$6.000K
YoY Change 236.75%
Interest Expense $6.250K $7.502K
YoY Change -16.69%
% of Operating Profit
Other Income/Expense, Net -$6.250K $46.87K
YoY Change -113.34%
Pretax Income -$26.46K $40.87K
YoY Change -164.74%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$26.46K $40.87K
YoY Change -164.74% -355.7%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$195.20
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 135.6M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.720K
YoY Change
Accrued Expenses $258.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $250.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $544.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $544.9K
Total Long-Term Liabilities $0.00
Total Liabilities $544.9K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$3.544M
YoY Change
Common Stock $141.9K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 375.0K shares
Shareholders Equity -$544.9K -$489.6K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$26.46K $40.87K
YoY Change -164.74% -355.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities $0.00 $0.00
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135569068 shares
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
258591 USD
CY2022Q1 ybcn Convertible Debentures Related Parties
ConvertibleDebenturesRelatedParties
250000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
544943 USD
CY2022Q1 us-gaap Liabilities
Liabilities
544943 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135569068 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
141945 USD
CY2021Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
375000 shares
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
252341 USD
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 USD
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
375 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2854388 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3517478 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-518488 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
20205 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
20205 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20205 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
54368 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-26455 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40866 USD
CY2022Q1 ybcn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2021Q1 ybcn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-518488 USD
CY2022Q1 ybcn Correction Of An Error
CorrectionOfAnError
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26455 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-544943 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-580457 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
50000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
40866 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-489591 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26455 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
40866 USD
CY2022Q1 ybcn Write Off Of Accrued Interest On Extinguished Debt
WriteOffOfAccruedInterestOnExtinguishedDebt
0 USD
CY2021Q1 ybcn Write Off Of Accrued Interest On Extinguished Debt
WriteOffOfAccruedInterestOnExtinguishedDebt
54368 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
284 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6000 USD
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
6250 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
7502 USD
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
19921 USD
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 ybcn Working Capital Deficit
WorkingCapitalDeficit
-544943 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26455 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
33637 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13716 USD
CY2022Q1 ybcn Recent Accounting Pronouncementsdisclosuretextblock
RecentAccountingPronouncementsdisclosuretextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management does not believe there would have been a material effect on the accompanying unaudited condensed financial statements had any recently issued, but not yet effective, accounting standards been adopted in the current period.</p>
CY2009Q3 ybcn Investor Relations Agreement Description
InvestorRelationsAgreementDescription
Pursuant to the agreement, the Company agreed to pay a fee of $1,000 per month for a period of six months beginning on August 1, 2009 and ending January 1, 2010. The Company must also issue 75,000 shares within 7 days of signing the agreement. Any payments over 45 days will be subject to a penalty fee of 10% per week.
CY2009Q3 us-gaap Other Commitment
OtherCommitment
1000 USD
CY2009Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
75000 shares
CY2009Q3 ybcn Penalty Fees
PenaltyFees
0.10 pure
CY2010Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares
CY2009Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD
CY2010Q1 ybcn Additional Shares Issued
AdditionalSharesIssued
75000 shares
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD

Files In Submission

Name View Source Status
0001477932-22-003757-index-headers.html Edgar Link pending
0001477932-22-003757-index.html Edgar Link pending
0001477932-22-003757.txt Edgar Link pending
0001477932-22-003757-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ybcn-20220331.xsd Edgar Link pending
ybcn-20220331_cal.xml Edgar Link unprocessable
ybcn-20220331_def.xml Edgar Link unprocessable
ybcn-20220331_lab.xml Edgar Link unprocessable
ybcn-20220331_pre.xml Edgar Link unprocessable
ybcn_10q.htm Edgar Link pending
ybcn_10q_htm.xml Edgar Link completed
ybcn_ex311.htm Edgar Link pending
ybcn_ex312.htm Edgar Link pending
ybcn_ex321.htm Edgar Link pending